Resources
For the latest in discovery & development, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Chemical Biology
Targeting Novel E3 Ubiquitin Ligases: Carles Galdeano, Professor, University of Barcelona
We discuss working on PROTACs, targeting novel E3 ubiquitin ligases, and Dr Galdeano's spin out Oniria Therapeutics.
Organ Modelling
Spheroids, Assembloids Could Unlock High Throughput Screening of Neuro Drugs
These spheroids can mimic different sections of the human brain based on their cell-type composition, and promisingly could enable high-throughput screening of neurology drugs.
Chemical Biology
Talking TPD with Ben Cross, CTO and Head of Platform at PhoreMost
Delving into PhoreMost's role in targeted protein degradation, the innovation behind the SITESEEKER platform, and the challenges and breakthroughs in the dynamic field of drug discovery.
Target Discovery
Pivot Park Screening Centre: We Help You to Accelerate Drug Discovery
Are you looking for lead candidate compounds for your target or cellular phenotype, and do you want your drug discovery program to be more efficient, both in terms of time and cost?
Molecular Drug Design
Interview with Sridevi Nagarajan, Head Digital Regulatory Strategy at AstraZeneca
AstraZeneca’s Sridevi Nagarajan discusses the importance of artificial intelligence, strategic collaboration, and the role of the metaverse in unlocking the future of digital regulatory.
Pharma Data
Funding Opportunity Announced for Generating Real-World Evidence in Regulatory Decision-Making
The U.S. Food and Drug Administration (FDA) is encouraging pharmaceutical developers to submit real-world evidence in support of regulatory applications.
Organ Modelling
Vascular Organoids used to Model the Impact of COVID-19 on Circulation
Researchers have used vascular organoids to look at the impact of SARS-CoV-2 on blood circulation, which has led to the discovery of a potential therapeutic target.
Medicinal Chemistry
Biophysical Tools for the Design and Development of PROTACs
Protein degradation has emerged as a promising new field of therapeutics. What are biophysical tools are employed for the characterisation of these drugs?
Chemical Biology
Challenges and Opportunities in Targeted Protein Degradation: Current and Future Strategies
Discussing the challenges and strategies in targeted protein degradation (TPD), a promising therapeutic modality with the potential to drug difficult or "undruggable" protein targets.
Molecular Drug Design
Revolutionizing Drug Discovery: The Power of AI in Drug Screening and Clinical Trials
Automation
Smart Labs for Smart Research: Advanced Robotic Solutions Through Automated Development
‘Smart labs’ is a term that is incredibly prevalent in the world of pharma data management. But what are the building blocks of these laboratories that are proving ever-more important in modern research?
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery